Novo Nordisk said that if approved for use ... and showed that it was equivalent to insulin glargine, another once-daily basal insulin, in glucose-lowering efficacy with a similar safety profile.

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir, arguing that it could leave some diabetics without an ...

Currently, Civica is making a long-acting insulin called glargine, most commonly sold ... which Danish drugmaker Novo Nordisk produces under the brand name NovoLog. Eventually, Civica expects ...

injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% ...

Globally Mounjaro, and peers in this category, Ozempic/Wegovy from Novo Nordisk ... sulfonylureas and insulin glargine. “Participants in the SURPASS program achieved average A1C reductions ...

In a study funded by Novo Nordisk, which manufactures Ozempic ... Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without ...

A U.S. federal court has approved a settlement between Novo Nordisk (NVO) and Minnesota ending a longstanding litigation that accused three leading insulin manufacturers of charging excessive ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain for investors.

Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.